Instruct3D Strengthens Additive Build Intelligence Message Following ICAM 2026 
Otto Group and Sereact Bring NVIDIA-Powered Physical AI to Returns Processing Summit Therapeutics Announces Commencement of Rights Offering
Summit Therapeutics Inc.(‘Summit’ or the ‘Company’) Summit Therapeutics Announces Commencement of Rights Offering Cambridge, MA,…
Excellthera and Ossium Health Announce a Collaboration to Advance Their Technologies and Platforms to Improve Human Health
MONTREAL, April 21, 2021 (GLOBE NEWSWIRE) — ExCellThera Inc., a clinical-stage cell and molecular medicine…
Enzo’s Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization
Company’s specimen collection kit now available for use in COVID-19 testing in the U.S. Sample…
Adverum Mails Letter to Stockholders Highlighting World-Class Board of Directors Overseeing Successful ADVM-022 Commercial Launch
Adverum Slate Background Adverum Slate Background Adverum Board Matrix Adverum Board Matrix Sonic’s Nominees Lack…
Vaccinex Announces Publication of Results from CLASSICAL-Lung Phase 1b/2 Clinical Trial in Non-Small Cell Lung Cancer in the Peer-Reviewed Journal Clinical Cancer Research
CLASSICAL-Lung study evaluated pepinemab in combination with the checkpoint inhibitor BAVENCIO® for the treatment of…
BriaCell CEO Gives Corporate Overview, Plans for Future in Audio Interview with SmallCapVoice.com
AUSTIN, Texas, April 21, 2021 (GLOBE NEWSWIRE) — SmallCapVoice.com Inc. (“SCV”) announces the availability of…
Ayala Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of AL102 in Combination with BCMA Targeting Agent, WVT078, in Patients with relapsed/refractory Multiple Myeloma
REHOVOT, Israel and WILMINGTON, Del., April 21, 2021 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (Nasdaq:…
Pharvaris Announces FDA Acceptance of IND Application for Prophylactic Treatment of HAE Using PHVS416
Company on track to initiate prophylactic study of PHVS416 ZUG, Switzerland, April 21, 2021 (GLOBE…
Brii Biosciences, Vir Biotechnology and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B
New combination trial of an RNA-targeted therapeutic candidate and an HBV immunotherapeutic candidate aimed at…
Mustang Bio to Participate in Chardan’s 5th Annual Genetic Medicines Manufacturing Summit
WORCESTER, Mass., April 21, 2021 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
Humacyte Announces Positive Long-Term Follow-Up Data from Phase 2 Vascular Access Trial
Five-year outcomes demonstrate HAV retained durability and structural integrity, potentially offering a safe and viable…
Replimune Appoints Genentech Global Oncology Franchise Head Sushil Patel, Ph.D. as Chief Commercial Officer
WOBURN, Mass., April 21, 2021 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a biotechnology…
NexImmune Appoints Chad Rubin as Senior Vice President, Corporate Affairs
Mr. Rubin most recently served as Managing Director, Co-Head Life Sciences for Solebury Trout GAITHERSBURG,…
Antios Therapeutics Doses First Patients in SAVE 1, a Phase 2a Study of ATI-2173 in Patients with Chronic Hepatitis B Virus (HBV)
SAVE 1 to evaluate ATI-2173 in combination with tenofovir (TDF) vs. TDF plus placebo SAVE…
Lowell Farms to Announce First Quarter Financial Results
Cannabis industry leader to hold conference call on May 5 SALINAS, Calif., April 21, 2021…
Cyclerion Therapeutics to Participate in the B. Riley Neuroscience Investor Conference
CAMBRIDGE, Mass., April 21, 2021 (GLOBE NEWSWIRE) — Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage…
Cerevel Therapeutics Appoints Abraham N. Ceesay as President
CAMBRIDGE, Mass., April 21, 2021 (GLOBE NEWSWIRE) — Cerevel Therapeutics, a company dedicated to unraveling…
Apellis Pharmaceuticals to Hold First Quarter 2021 Earnings Conference Call on April 28, 2021
WALTHAM, Mass., April 21, 2021 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…
Tonix Pharmaceuticals to Participate in Fourth Annual Neuroscience Innovation Forum
CHATHAM, N.J., April 21, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix…
Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation Forum
BOTHELL, Wash., April 21, 2021 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage…